RESEARCH DOSSIER
Neuroimmune Signaling and Behavioral Regulation
Abstract. Neuroimmune signaling and behavioral regulation encompass the reciprocal communication processes through which immune activity changes neural function and behavioral allocation, while neural and neuroendocrine systems modify immune responses. This fundamental research monograph critically synthesizes historical psychoneuroimmunology, cytokine-dependent sickness behavior, peripheral-to-central neural and humoral routes, brain-border immunity, microglial contributions to development, autonomic inflammatory control, controlled human endotoxin experiments, and translational research on motivation, fatigue, social experience, reward, and depression. The evidence base includes foundational animal perturbation experiments, human randomized inflammatory challenges, observational neuroimaging and clinical studies, an anti-inflammatory randomized controlled trial, and major contemporary mechanistic reviews through 2026. The synthesis distinguishes peripheral biomarkers from demonstrated central signaling, acute experimentally induced states from persistent clinical syndromes, and associations from causal findings. It identifies strong experimental evidence for selected acute immune–behavior relationships, substantial pathway and population heterogeneity, and important limitations in using inflammatory biomarkers to infer individual psychiatric mechanisms or treatment benefit. The concluding framework specifies anatomical location, signal identity, temporal dynamics, and behavioral construct as necessary elements of testable explanations. This work is a critical narrative synthesis of identified scholarly research; it reports no newly collected participant data, registered systematic-review protocol, pooled meta-analysis, diagnostic assessment, or individual treatment guidance.
Keywords: neuroimmune signaling; psychoneuroimmunology; sickness behavior; inflammation; cytokines; immune-to-brain communication; vagus nerve; inflammatory reflex; microglia; meningeal immunity; reward processing; fatigue; anhedonia; social motivation; behavioral regulation; stress; neuroinflammation
Introduction: Neuroimmune Communication as a Behavioral System
Neuroimmune signaling and behavioral regulation concern the reciprocal processes through which immune activity informs neural systems and neural activity reorganizes immunity, altering the probability, timing, and intensity of behavior. The central research object is the mechanism linking immune detection, signal transmission, circuit computation, subjective experience, and observable action. Infection-related social withdrawal, diminished reward pursuit, reduced appetite, changes in sleep, fatigue, and heightened threat sensitivity are distinct outcomes requiring distinct measures. Their convergence during illness motivates a coordinated explanation, while differences among them challenge an account based on a single inflammatory variable. The field joins behavioral neuroscience, immunology, affective science, and experimental psychopathology. Dantzer et al. (2008) Bower & Kuhlman (2023) Wheeler & Quintana (2025)
The phrase neuroimmune signaling covers molecules, cells, anatomical routes, and timing. Cytokines such as interleukin-1 beta, interleukin-6, and tumor necrosis factor signal within immune tissues and at brain interfaces. Afferent neural routes, vascular endothelial signaling, circumventricular structures, meningeal compartments, and glia participate in converting peripheral disturbances into central responses. Conversely, autonomic and neuroendocrine outputs alter immune-cell trafficking and inflammatory activity. Each proposed pathway has its own boundary conditions. Peripheral cytokine concentration is an informative but incomplete indicator of neural exposure, and changes in brain activity alone cannot identify the causal immune messenger. Maier et al. (1998) Tracey (2002) Smyth & Kipnis (2025)
This monograph evaluates the historical construction of the field, mechanistic animal experiments, controlled human inflammatory challenges, longitudinal correlational evidence, intervention trials, and recent anatomical advances. It applies a critical narrative synthesis, weighing perturbation evidence more strongly for causal pathways than simultaneous biomarker–symptom correlations. No new participant data, preregistered systematic search, quantitative meta-analysis, clinical treatment recommendation, or claim of a single universal mechanism is presented. The guiding question is how specific neuroimmune routes regulate behavioral choice under infection, stress, recovery, and chronic disease, and which links have been established across species rather than proposed by analogy. Konsman et al. (2002) Eisenberger et al. (2010b) Raison et al. (2013)
Definitions: Sickness Behavior, Neuroinflammation, and Regulation
Sickness behavior denotes an organized constellation of illness-associated alterations in activity, feeding, social engagement, sleep, exploration, and motivational priorities. It is an experimentally tractable phenotype, traditionally modeled after exposure to immune stimuli, rather than a psychiatric diagnosis. Neuroinflammation denotes inflammatory processes involving nervous-system tissue or its interfaces; a raised concentration of a peripheral inflammatory marker alone does not establish this process inside the brain. Neuroimmune regulation refers to feedback relationships among neural signals, immune responses, and their functional consequences. Using these definitions prevents a laboratory increase in a circulating cytokine from being mistaken for direct evidence of a pathological brain state. Hart (1988) Konsman et al. (2002) Miller & Raison (2016)
Behavioral regulation here means an alteration of action allocation relative to environmental demands and bodily state. An animal that delays food seeking while responding to infection may be reallocating resources; an individual reporting anhedonia may demonstrate a selective change in anticipated reward rather than an absolute inability to act. Fatigue involves experienced effort or exhaustion, whereas motor slowing concerns measurable performance. Negative affect, motivation, cognition, and arousal overlap but remain separable outcome domains. A mechanistic investigation must predefine whether it measures spontaneous locomotion, effort expenditure, reward learning, self-reported pleasure, attention, or social approach. Interchangeable use of these outcomes produces misleading generalizations. Dantzer et al. (2008) Eisenberger et al. (2010b) Boyle et al. (2026)
Immune-to-brain communication, brain-to-immune communication, and developmental immune–neural interaction represent three related but distinguishable directions of influence. The first asks how peripheral immune signals alter brain function; the second asks how neural outputs regulate immune state; the third examines how immune components participate in constructing functional neural circuits. Temporally restricted adaptive inflammation and persistent inflammatory dysregulation also require separation. A brief response useful during acute illness can become costly when extended, recurrent, or expressed in an inappropriate context. This temporal and functional framework guides interpretation of laboratory sickness, chronic depressive symptoms, and inflammatory effects on development. Tracey (2002) Schafer et al. (2012) Estes & McAllister (2016)
Historical Formation of Psychoneuroimmunology
Historical work that helped establish neuroimmune research questioned the traditional separation of the immune, nervous, and endocrine systems. Blalock's 1984 account of the immune system as a sensory organ supplied an influential framework in which immune cells detect bodily events and communicate their consequences. Hart's 1988 analysis of illness behavior proposed that reduced activity and altered feeding could express organized defense rather than undifferentiated incapacity. These proposals defined testable questions about signaling routes and adaptive function. Their historical importance rests on the research programs they stimulated; whether any particular behavioral response increases survival must still be demonstrated within the organism and ecological conditions examined. Blalock (1984) Hart (1988)
During the 1990s, experimental studies of interleukin-1 and inflammatory challenges moved the field toward specific pathways. The synthesis by Maier and Watkins identified bidirectional immune–brain communication as a problem for psychology, linking bodily inflammation with affect, cognition, and behavior. Vagal afferent experiments explored rapid neural relays alongside blood-borne routes. The route of immune administration mattered: interventions affecting responses to an intraperitoneal stimulus did not automatically block responses delivered by other routes. This empirical nuance already indicated that the brain receives multiple types of immune information rather than a single uniform inflammatory message. Maier & Watkins (1998) Maier et al. (1998) Dantzer et al. (1998)
At the beginning of the twenty-first century, molecular models of cytokine-induced sickness were joined by neural feedback concepts. Konsman and colleagues summarized fast neural and slower humoral routes, while Tracey's inflammatory reflex emphasized autonomic control of cytokine activity. Subsequent investigations introduced controlled human inflammatory challenges, neuroimaging of reward circuits, and identification of previously underappreciated meningeal lymphatic structures. The disciplinary trajectory moved from an analogy between sickness and depression toward a more differentiated account of pathways, cell types, behaviors, and conditions of translation. This history is best understood as cumulative methodological expansion, including revision of older assumptions about cerebral immune isolation. Konsman et al. (2002) Tracey (2002) Louveau et al. (2015)
Immune Signals, Receptors, and Temporal Dynamics
Innate immune detection of microbial products and tissue damage recruits molecular programs that produce cytokines, chemokines, lipid mediators, and other signals. Their behavioral effects depend on ligand identity, receptor expression, cellular source, dose, route, duration, and preceding immune state. Interleukin-1 signaling has an especially substantial experimental history in sickness behavior, but even this cytokine operates within interacting networks rather than in isolation. Proinflammatory and resolution-oriented responses arise on different timescales. A single blood measurement can conceal an earlier peak, delayed central response, or rapid compensatory mechanism. Studies therefore need serial measurements aligned with the specific behavioral task or clinical observation. Dantzer et al. (1998) Konsman et al. (2002) Bower & Kuhlman (2023)
The mapping from a blood cytokine to a behavioral phenotype cannot be treated as one-to-one. Cytokines act locally, bind soluble receptors, vary with sleep and sampling conditions, and communicate across endothelial and cellular intermediaries. Some experimentally observed effects depend on induced central signaling rather than transport of the intact peripheral molecule into neural tissue. Human challenge studies provide informative temporal sequences because the inflammatory stimulus precedes measurement of circulating mediators, neural responses, and affect. Such experiments still reveal the effect of a compound inflammatory perturbation; they do not isolate every cytokine's independent causal contribution. Selective blockade and receptor-specific animal experiments offer complementary tests. Maier et al. (1998) Dantzer et al. (2008) Eisenberger et al. (2010b)
A satisfactory kinetic account specifies initiation, propagation, amplification, resolution, and any subsequent altered sensitivity. Rapid protective signaling can increase vigilance or suppress exploration during infection; prolonged or repeated stimulation can influence broader neurobehavioral systems. Baseline health, age, sex-related biological variation, medication, prior infection, metabolic state, and circadian phase can change both biomarker trajectories and behavioral response. The predictive target should be a time-resolved relationship, not merely whether an individual has high inflammation. This approach also clarifies why sampling peripheral inflammatory markers at a single clinic visit supplies limited mechanistic information about persistent fatigue or depressed mood. Miller et al. (2002) Slavich & Irwin (2014) Wheeler & Quintana (2025)
Peripheral-to-Central Communication: Neural Routes
Afferent neural pathways rapidly convey physiological information from peripheral organs to brainstem and forebrain systems. The vagus nerve became central to this research because inflammatory stimulation can influence vagal afferent activity and downstream sickness responses. Early studies using vagotomy provided evidence of neural mediation under particular routes of cytokine or lipopolysaccharide administration. The crucial inference is conditional: severing a pathway that changes a response shows that pathway contributes to that experimental configuration, while preserved effects with other administration routes demonstrate additional pathways. Vagal mediation cannot be generalized to every immune signal or behavioral change. Maier et al. (1998) Dantzer et al. (1998)
The nucleus tractus solitarius and its projections offer a plausible neural entry system for visceral immune-related signals. Integrating signals at these sites can influence hypothalamic autonomic and endocrine control, arousal, feeding, and defensive behavior. At the same time, immune messages may activate spinal afferents or indirectly engage central networks through physiological disturbances such as fever or altered metabolism. An experiment that measures a neural response after immune challenge should compare sensory, endocrine, and metabolic alternatives. Identifying the relevant relay demands anatomical tracing, recording during the immune perturbation, and selective interference that respects baseline neural function. Maier & Watkins (1998) Konsman et al. (2002) Wheeler & Quintana (2025)
Human vagal physiology introduces additional complexity. Surface markers of autonomic balance, including heart-rate variability, have multiple determinants and cannot independently identify a vagal inflammatory reflex or confirm afferent cytokine detection. Likewise, vagus nerve stimulation has potential immune consequences but depends on stimulation settings, target fibers, and clinical condition. A rigorous translational bridge should specify the neural population engaged, the relevant target organ, the time course of immune change, and an accompanying behavioral outcome. The field's strongest claim is that experimentally defined neural routes can contribute to immune-to-brain signaling, with substantially more uncertainty about mapping a particular peripheral autonomic measure to a specific central inflammatory event. Tracey (2002) Leunig et al. (2025) Wheeler & Quintana (2025)
Blood, Vascular, and Brain-Border Pathways
Peripheral inflammation reaches central regulatory systems through several anatomical interfaces. Circumventricular regions with specialized vascular properties, brain endothelial cells, choroid plexus, and the meningeal environment can detect immune-derived signals. The blood–brain barrier regulates exchange through specialized cellular and molecular arrangements; its existence is compatible with communication that is selective, indirect, and condition dependent. A cytokine can affect brain physiology through endothelial signaling without requiring wholesale barrier disruption. Thus, serum elevation, altered cerebrospinal fluid composition, and parenchymal immune activity are three measurements with different meanings. Dantzer et al. (2008) Smyth & Kipnis (2025) Kovacs et al. (2025)
The identification of functional meningeal lymphatic vessels by Louveau and colleagues in 2015 altered the anatomical account of immune surveillance and drainage. Their experimental work described lymphatic-like vessels near dural sinuses capable of carrying fluid and immune components toward cervical lymph nodes. Later synthesis emphasized that brain border tissues are active components of an immune interface rather than inert boundaries. This discovery does not establish that ordinary mood changes arise through meningeal lymphatic flow. It does require researchers examining immune-brain exchange to distinguish brain parenchyma, border tissues, cerebrospinal fluid, and lymphatic drainage. Louveau et al. (2015) Smyth & Kipnis (2025)
Blood, vascular, and border pathways are plausible sources of behavioral regulation because they can ultimately alter local neural excitability or recruit central inflammatory programs. Yet their contribution must be tested separately for acute infection, chronic inflammatory illness, and ordinary variation in psychosocial stress. Human sampling commonly includes plasma and sometimes cerebrospinal fluid, whereas tissue-specific mechanistic experiments are largely animal based. Changes in peripheral markers may reflect metabolic conditions, infections, or treatments unrelated to the hypothesized neural route. Causal inference improves when peripheral challenge, central intermediate measures, and behavior are aligned in time and when alternative physiology is measured rather than assumed absent. Bower & Kuhlman (2023) Kovacs et al. (2025) Wheeler & Quintana (2025)
Microglia, Astrocytes, and Local Neural Immune Activity
Microglia are resident immune-related cells that survey the central nervous system and respond to changes in local conditions. Their functions span surveillance, phagocytosis, immune signaling, and interactions with synapses; the word activation conceals considerable cellular heterogeneity. Astrocytes and other neural-associated cells also contribute to inflammatory communication and metabolic support. In infection models, peripheral signals can induce local cytokine production and coordinated behavioral changes. However, a histological change in microglial shape alone provides limited evidence about whether a particular behavior depends on a specific cell state. Cell-resolved molecular profiles, temporal tracking, and interventions are needed to distinguish candidate mechanisms. Dantzer et al. (2008) Wheeler & Quintana (2025) Kovacs et al. (2025)
Microglial participation in normal development demonstrates that immune-related cells have important functions beyond inflammation during disease. Schafer and colleagues showed in a postnatal mouse visual circuit that microglia engulf presynaptic inputs in an activity- and complement-related process; disruption of receptor signaling altered synaptic refinement. This result identifies a cellular mechanism for circuit organization. It does not mean that all pruning in all regions or species uses the identical mechanism, nor that a behavioral diagnosis can be inferred from one developmental pathway. The experiment supplies an example of how immune-associated mechanisms may influence the architecture on which later behavior depends. Schafer et al. (2012) Estes & McAllister (2016)
Neuroimmune research must distinguish microglial functions in development, everyday tissue maintenance, acute infection, and persistent pathology. Markers selected for one condition may identify different cell states under another. Tissue dissociation, single-cell profiling, imaging, and molecular perturbation each introduce selection effects and technical limitations. The strongest mechanistic programs combine evidence of cellular change with regionally specific neural physiology and appropriately controlled behavioral assays. Anatomical and cell-state advances make it possible to ask more precise questions about neuroimmune circuits, while the challenge of assigning a discrete psychological function to a molecular profile remains substantial. Schafer et al. (2012) Wheeler & Quintana (2025) Smyth & Kipnis (2025)
Sickness Behavior as Coordinated Motivational Reallocation
Sickness behavior encompasses a profile of changed priorities rather than a simple decrement across all behaviors. Reduced exploration, altered food intake, lower spontaneous locomotion, social withdrawal, and sleep changes frequently co-occur following an acute immune challenge. Hart's account framed these behaviors as an organized response that may conserve resources during infection, while later cytokine research identified molecular initiators and neural relays. A functional explanation must specify what costs are saved, what defensive benefits arise, and how these vary across illness severity. Because adaptive value is a hypothesis about fitness consequences, controlled observations of behavior alone cannot establish the evolutionary advantage of a response. Hart (1988) Konsman et al. (2002) Dantzer et al. (2008)
The timing of sickness behavior helps distinguish transient immune defense from chronic dysregulation. An animal may reduce activity when inflammatory signals rise and resume exploration as the response resolves. Some forms of reduced behavior can be overridden by sufficiently important incentives, indicating context-dependent choice rather than physical incapacity. Experimental protocols therefore need motivation-sensitive tasks, locomotor controls, body-temperature measurements, and repeated observation. A drug or immune manipulation that changes feeding may also influence nausea, pain, sensory function, or motor capacity. The resulting behavior is an integrated outcome of multiple processes and should be interpreted against measurements of these alternatives. Dantzer et al. (1998) Konsman et al. (2002) Dantzer et al. (2008)
For human psychology, sickness behavior becomes useful when its component domains are measured separately. Self-report can characterize perceived fatigue, malaise, social disconnection, or anhedonia; structured tasks can quantify effort expenditure, speed, attentional allocation, and reward sensitivity. Their correspondence may be imperfect, and individual reports may respond to expectations or contextual meaning. The scientific task is to explain why an immune challenge changes some functions more than others, including cases where a person experiences unpleasant symptoms while preserving goal-directed action. Such differentiation provides a stronger basis for comparing infection-related changes with psychiatric symptoms than relying on descriptive resemblance. Bower & Kuhlman (2023) Eisenberger et al. (2010b) Boyle et al. (2026)
Inflammation, Reward Anticipation, and Anhedonia
Anhedonia is commonly defined by reduced interest or pleasure, but reward systems contain multiple computations: anticipation, effort, learning, valuation, and consummatory enjoyment. Immune activation can affect these components differently. In a randomized endotoxin study, Eisenberger and colleagues examined neural responses while participants anticipated monetary rewards. Compared with placebo, endotoxin altered ventral striatal responses and depressed mood, supporting a causal effect of the inflammatory challenge on a reward-related neural outcome in that experimental setting. The experiment does not prove that every instance of anhedonia has inflammatory origins or that a single cytokine accounts for the observed effect. Eisenberger et al. (2010b) Miller & Raison (2016)
Anatomical reward circuitry includes corticostriatal systems whose functional signals are influenced by dopamine and many other mediators. Felger and colleagues investigated medically stable unmedicated patients with depression and reported associations between inflammatory biomarkers and decreased connectivity in corticostriatal reward circuitry. Such observational imaging findings support a plausible bridge between inflammation and motivation but cannot alone determine causal direction. Depression-related behavior, sleep disturbance, metabolic state, and medication histories can influence immune measurements and brain activity. Reward-task imaging, resting-state connectivity, and everyday goal pursuit should therefore be understood as complementary measurements rather than interchangeable evidence. Felger et al. (2016) Miller & Raison (2016)
A randomized double-blind inflammatory-challenge experiment reported in 2026 by Boyle and colleagues evaluated anhedonia and social reward in forty female adults aged twenty-five to forty-four, with eighteen receiving endotoxin and twenty-two receiving placebo. The abstract reports greater anhedonia and diminished social motivation after endotoxin, while changes in positive-cue attention were more limited. This distinction matters: impairment in one reward-related domain need not entail generalized withdrawal from all positive information. The study offers a contemporaneous causal manipulation with a restricted sample, short observation window, and composite inflammatory stimulus. It supports pathway-specific investigation while leaving long-term disorder mechanisms and broader demographic transportability unresolved. Boyle et al. (2026) Eisenberger et al. (2010b)
Fatigue, Effort, and Psychomotor Function
Fatigue is a major subjective and behavioral outcome of inflammatory illness, yet it encompasses perceived exertion, diminished persistence, reduced initiation, and central or peripheral physiological constraints. These dimensions can be separated through effort-based decision tasks, timed motor performance, endurance measures, and repeated self-report. Cytokine therapy observations established that immune activation in medically treated patients can accompany symptoms of malaise and depression, although treatment populations also experience complex illness burdens. To infer a neuroimmune mechanism for fatigue, a study must characterize the immune manipulation or exposure, control for illness severity, and establish whether the change concerns effort valuation, motor capacity, or both. Capuron et al. (2000) Bower & Kuhlman (2023) Dantzer et al. (2008)
The relationship between fatigue and motivation is often circular: reduced reward value may increase perceived effort, while perceived fatigue may suppress initiation even when rewards remain desirable. Inflammatory signaling provides one candidate contributor to this coupling through effects on central arousal, neuromodulatory activity, and interoceptive state. But causal specificity is difficult because fever, sleep disruption, pain, reduced food intake, and depressive symptoms co-occur in many inflammatory paradigms. A well-designed experiment pairs effort or willingness-to-work tasks with motor and affective controls and samples measurements repeatedly around the inflammatory response. Miller & Raison (2016) Eisenberger et al. (2010b) Bower & Kuhlman (2023)
Clinical descriptions should likewise distinguish acute infection-related fatigue from persistent fatigue syndromes, inflammatory comorbidity, medication effects, and mood disorders. A modest cytokine association in an observational cohort cannot establish that cytokine blockade will improve fatigue, and effects seen under controlled endotoxin exposure may dissipate within hours. Research on persistent symptoms requires prospective designs, attention to measurement error, evaluation of functional impairment, and explicit analysis of potentially competing mechanisms. This distinction protects the field's strongest laboratory findings while allowing carefully specified questions about chronic disease and disability to be tested. Raison et al. (2013) Bower & Kuhlman (2023) Wheeler & Quintana (2025)
Sleep, Arousal, Appetite, and Energy Allocation
Sleep, arousal, appetite, and immune function are mutually linked. The sickness response can alter sleep architecture, induce drowsiness, suppress feeding, and change thermoregulation. These changes may jointly redistribute energy and attention during infection, but they should not be treated as one unitary behavior. Sleep duration does not necessarily index restorative quality; reduced feeding can reflect altered appetite, nausea, or metabolic signals; and quiet wakefulness differs from sleep. Sickness behavior research therefore benefits from concurrent polysomnographic or actigraphic measures, food intake and metabolic monitoring, and state-dependent behavioral testing. Hart (1988) Dantzer et al. (2008) Bower & Kuhlman (2023)
Circadian timing complicates inflammatory measurement and behavioral interpretation. Immune-cell trafficking and endocrine regulation vary across the day, and sleep deprivation can change peripheral cytokine measurements. An immune challenge delivered at different times may therefore recruit different baseline states. Conversely, behavior induced by inflammation can alter later immune responses through changes in sleep, nutrition, and activity. This reciprocal pattern makes temporal ordering essential to explanatory claims. Repeated observations, planned sampling intervals, and adjustment for relevant circadian and health covariates can reveal whether a supposed direct cytokine–mood association is mediated by altered arousal or sleep. Miller et al. (2002) Leunig et al. (2025) Bower & Kuhlman (2023)
Feeding-related regulation illustrates the need to distinguish central motivational mechanisms from peripheral physiology. In some inflammatory paradigms, animals eat less, while changes in body temperature, gastrointestinal signaling, and metabolic requirements occur simultaneously. A behavioral test of appetitive motivation should control for food palatability, gastrointestinal symptoms, and physical ability to obtain food. In human studies, an illness-linked reduction in appetite cannot be assumed to reflect the same neural mechanism as lower interest in social contact. Shared inflammatory initiation may produce separable outputs, and the magnitude of each outcome will depend on the environment and the organism's current priorities. Konsman et al. (2002) Dantzer et al. (2008) Wheeler & Quintana (2025)
Pain, Threat Sensitivity, and Defensive Behavior
Neuroimmune signaling also participates in changes in pain sensitivity and defensive behavior. Peripheral inflammatory mediators can sensitize nociceptive pathways, while central glial and neural interactions modify the response to sensory input. Early immune-to-brain research examined cytokine-related hyperalgesia and its neural transmission routes. This evidence helps explain why illness-associated behavior may include withdrawal from touch or movement as well as reduced exploratory motivation. Pain, however, is a distinct sensory and affective outcome. A reduction in activity after immune challenge may partly reflect discomfort, so interpreting it as anhedonia without measuring pain can misidentify the mechanism. Maier et al. (1998) Watkins & Maier (1999)
Threat sensitivity is linked to inflammation in models describing interactions between defensive states, reward processing, and social appraisal. Elevated vigilance and avoidance can be useful in one environment but costly in another. The same immune state may therefore lead to different overt behavior depending on cue meaning, access to support, and task demands. Behavioral experiments should include both threat and reward conditions, measure baseline anxiety or fear-related performance, and examine whether the immune manipulation changes sensory acuity or response speed. This allows an inference about defensive decision processes rather than relying on a global activity score. Slavich & Irwin (2014) Miller & Raison (2016) Bower & Kuhlman (2023)
A causal model of inflammation-related pain or threat must specify its level of analysis. Receptor-specific neural manipulations can identify local signaling mechanisms; human symptom scales can establish patient relevance; neuroimaging can relate circuits to behavioral outcomes. None of these approaches alone establishes the complete peripheral-to-behavioral route. Inflammatory challenges may affect physiological arousal, nociception, and valuation simultaneously, and mediation analyses must be interpreted within the assumptions of their causal design. A mature account seeks convergent evidence rather than reducing complex defensive behavior to a single marker labeled inflammation. Watkins & Maier (1999) Dantzer et al. (2008) Wheeler & Quintana (2025)
Cognition, Learning, and Neuroimmune Modulation
Cognitive outcomes attributed to inflammation include changes in attention, working memory, learning, and decision-making, but results differ across tasks and experimental contexts. A lower score after an inflammatory stimulus could reflect reduced attention or motivation, slower responding, pain, or more direct changes in memory processes. This ambiguity is especially important when testing patients who are ill or fatigued. Task design should measure effort, reaction time, error patterns, and practice effects while distinguishing performance at encoding, retention, and retrieval. Immune challenge studies with carefully timed controls provide one route to separating short-lived state effects from stable cognitive impairments. Maier & Watkins (1998) Bower & Kuhlman (2023)
Evidence that immune-related cells shape neural development adds a second, temporally distinct pathway from inflammation to cognition. In mice, microglial complement-related synaptic refinement can affect connectivity during an early sensitive period; meningeal immune-cell studies have also suggested roles for immune signaling in learning and memory. These experiments support the broader principle that immune functions contribute to neural organization, but translating their cellular manipulations into human everyday cognition requires additional developmental and behavioral validation. An experimental change in a rodent spatial task is evidence about that task and mechanism, not a universal cognitive effect of the immune system. Schafer et al. (2012) Derecki et al. (2010)
Developmental immune exposure presents a particularly demanding inference problem. Maternal infection and immune activation have been associated with later neurodevelopmental outcomes in epidemiological and animal-model literature, yet maternal health, timing, genetics, and many environmental factors complicate interpretation. The research tradition reviewed by Estes and McAllister connects experimental maternal immune activation with altered offspring neural function, while emphasizing questions of model validity. Generalizing from acute adult sickness responses to prenatal developmental trajectories would conflate fundamentally different exposures. The relevant mechanisms, sensitive periods, follow-up measures, and causal counterfactuals must be explicitly specified for each research question. Estes & McAllister (2016) Schafer et al. (2012) Bower & Kuhlman (2023)
Brain-to-Immune Regulation and the Inflammatory Reflex
The reciprocal direction of neuroimmune communication is demonstrated by neural control of inflammatory physiology. Autonomic pathways influence vascular regulation, organ function, and immune-cell behavior. Tracey's inflammatory reflex framework proposed that neural circuitry can detect inflammatory disturbance and recruit cholinergic mechanisms that limit cytokine production. This was a decisive conceptual development because it made immunity a target of nervous-system regulation alongside functions traditionally understood through reflex control. The framework is mechanistic when its neural pathways, receptors, target immune populations, and physiological outcomes are experimentally identified, rather than when any autonomic change is loosely described as anti-inflammatory. Tracey (2002) Leunig et al. (2025)
Neural control of immunity occurs through multiple routes and timescales. Sympathetic and parasympathetic inputs, neuroendocrine mediators, and behavioral actions influence immune-cell mobilization, development, distribution, and activity. These effects vary by tissue and stimulus. A reduction in one cytokine following neural stimulation does not imply generalized immunosuppression, beneficial clinical outcome, or improved psychological well-being. Biological effects can depend on where an immune response is needed and on whether suppression hinders host defense. The newer spatial and temporal framework of Leunig and colleagues makes this tissue- and phase-specificity explicit, encouraging assays of immune function beyond a single circulating protein. Leunig et al. (2025) Tracey (2002) Wheeler & Quintana (2025)
The strongest tests intervene at a specified neural node while tracking downstream immune outcomes and relevant function. Selective stimulation, neural recording, receptor antagonism, and anatomical tracing can identify pieces of a pathway; each requires controls for changes in heart rate, circulation, metabolism, and stress. Translation to humans demands attention to stimulation anatomy, protocol, clinical condition, and reproducibility. The term reflex must not become a shortcut for an unverified causal chain. A scientifically informative intervention identifies the relevant afferent input, processing pathway, efferent output, cellular target, and resulting immune and behavioral phenotype with an explicit temporal sequence. Tracey (2002) Wheeler & Quintana (2025) Leunig et al. (2025)
Stress Biology, Glucocorticoids, and Immune Feedback
Psychosocial stress is one route through which behavioral contexts may alter immune physiology. The stress response recruits sympathetic signaling, hypothalamic–pituitary–adrenal activity, behavioral changes, and immune regulation. Acute responses can mobilize resources in a changing environment, while prolonged exposure may alter sensitivity to regulatory signals. Miller, Cohen, and Ritchey examined adults experiencing chronic caregiving-related stress and reported evidence compatible with reduced glucocorticoid suppression of stimulated inflammatory cytokine production. Their study provides an empirical example of altered regulatory sensitivity. The design also illustrates the difficulty of separating caregiving stress from sleep, disease exposure, household resources, and behavioral differences. Miller et al. (2002)
Glucocorticoid resistance is a mechanistic hypothesis about the responsiveness of target cells to hormonal control. It should be examined with appropriate challenge assays and cellular readouts, not inferred simply from a single cortisol measurement. The magnitude and direction of an inflammatory response can vary with circadian phase, repeated stress, immune history, and the type of challenge. Interactions of neural and immune systems are thus conditional and dynamic. An association between distress and higher C-reactive protein may motivate a hypothesis, but a causal claim requires ruling out shared determinants such as adiposity, infection, medication, smoking, and altered activity. Miller et al. (2002) Slavich & Irwin (2014) Bower & Kuhlman (2023)
Social signal transduction theory places social threat appraisal upstream of physiological programs that may increase inflammatory signaling and modify depressive risk. This is a fruitful multilevel model because it generates predictions connecting neural representations, autonomic or endocrine activity, molecular processes, and symptom dimensions. A test should establish temporality, specify mediators and confounders, and evaluate plausible alternative pathways. Even where chronic stress predicts inflammation or illness, that does not establish that inflammation mediates the complete psychological effect of the exposure. Stronger programs combine repeated observations with interventions that modify the proposed upstream stress process or downstream immune route. Slavich & Irwin (2014) Miller et al. (2002) Miller & Raison (2016)
Inflammation and Depressive Symptom Dimensions
The relation between inflammation and depression is scientifically important because some depressive features resemble aspects of sickness behavior, including fatigue, reduced activity, appetite change, and anhedonia. Clinical depression is, however, a heterogeneous disorder defined through a broader clinical assessment. The cytokine hypothesis describes immune-mediated pathways that may contribute to symptoms in particular people or contexts. Dantzer and colleagues developed the distinction between transient cytokine-driven sickness and potentially persistent mood disturbances. Miller and Raison emphasized how immune pathways might influence neural systems relevant to depression and how clinical heterogeneity affects therapeutic interpretation. Dantzer et al. (2008) Miller & Raison (2016)
Exogenous immune stimulation supplies a causal line of evidence. Capuron and colleagues described depressive symptoms among cancer patients receiving cytokine-based treatments; such observations establish clinically relevant temporal relationships while requiring caution about underlying disease and treatment context. Randomized endotoxin investigations offer cleaner short-term experimental controls and have identified depressed mood and reward-related changes. These approaches converge on biological plausibility, yet the induced immune response of a healthy volunteer is short-lived and differs from the changing physiology and life context of major depressive disorder. Extrapolation across timescale and population therefore requires independent validation. Capuron et al. (2000) Eisenberger et al. (2010b) Boyle et al. (2026)
Observational studies support associations between inflammatory markers and depressive features, including reward-related brain connectivity in selected samples. Such evidence identifies candidates for mechanistic follow-up, not an inflammatory etiology shared by all depression cases. Alternative causal explanations include illness-related inflammation, stress, sleep impairment, obesity, reduced activity, and selection into care. A stronger translational model distinguishes psychomotor slowing, reward anticipation, social withdrawal, sleep, and subjective sadness; evaluates repeated inflammatory profiles; and tests targeted interventions in biologically characterized groups. The empirical question becomes which pathways contribute to which symptom dimension under which conditions rather than whether depression as a whole is inflammatory. Felger et al. (2016) Slavich & Irwin (2014) Miller & Raison (2016)
Anti-Inflammatory Intervention Trials and Translational Limits
Intervention research provides an important test of whether inflammation contributes causally to a psychological outcome. Raison and colleagues conducted a randomized trial of infliximab, a tumor necrosis factor antagonist, for treatment-resistant depression. The overall clinical result did not establish a general antidepressant benefit; analyses suggested that baseline inflammatory status might influence response. This pattern illustrates the difficulty of targeting a heterogeneous diagnosis with an immune intervention and the methodological importance of specifying biomarkers and subgroups before interpreting clinical findings. Post hoc subgroup patterns are hypothesis-generating until independently replicated with adequately powered prospective designs. Raison et al. (2013) Miller & Raison (2016)
Reducing inflammatory markers is an intermediate physiological outcome; improving clinically meaningful symptoms, functioning, and quality of life is a distinct goal. Therapies may have direct neural, metabolic, or behavioral effects beyond immune regulation. Adverse effects, infection risk, costs, and medical indications require consideration in any assessment of clinical use. For research purposes, trial interpretation should evaluate randomization, allocation, blinding, endpoint selection, adverse-event reporting, baseline biomarker distribution, and prespecified interaction tests. A null overall result does not establish that no immune-related symptom pathway exists, just as a significant subgroup result does not prove routine clinical effectiveness. Raison et al. (2013) Bower & Kuhlman (2023)
The translational path from mechanistic studies to interventions is therefore staged. Animal experiments can establish receptor or circuit dependence; human challenges can show time-limited causal effects; observational cohorts can characterize clinical associations; randomized trials assess whether manipulating a target improves a defined outcome. This sequence should preserve the distinctions among prevention, treatment of inflammatory illness, and treatment of psychiatric symptoms. Controlled immune modulation should not be proposed as self-treatment on the basis of laboratory sickness studies. The field's mature standard is to seek replicable changes in functional outcomes with acceptable safety within clearly specified clinical populations. Raison et al. (2013) Miller & Raison (2016) Wheeler & Quintana (2025)
Developmental Neuroimmune Interaction and Sensitive Periods
Neuroimmune pathways influence the developing nervous system through roles in circuit formation, developmental signaling, and responses to environmental challenge. Microglial involvement in synapse removal illustrates a normal component of neural maturation, whereas maternal immune activation experiments concern perturbation of development under an inflammatory exposure. These mechanisms differ in timing and inference. Schafer and colleagues identified complement-related microglial participation in a specific mouse circuit, while the maternal immune activation literature evaluates offspring behavior after controlled gestational exposure. Neither research line can be reduced to the claim that inflammation uniformly harms cognitive development. Schafer et al. (2012) Estes & McAllister (2016)
Developmental exposures are challenging because the stage of gestation, identity of the immune stimulus, maternal condition, fetal response, and later environment all influence outcomes. Animal models offer experimental control and molecular access, but species differences in neurodevelopment and immune physiology constrain translation. Human epidemiology provides population relevance yet may involve infections, obstetric factors, socioeconomic conditions, and genetic susceptibility that are hard to disentangle. A scientifically useful model requires explicit identification of the putative exposure, sensitive period, intermediate mechanism, and measurable developmental outcome, preferably supported by convergent designs. Estes & McAllister (2016) Bower & Kuhlman (2023)
Developmental findings belong within this dossier because they show that neuroimmune communication can shape later behavior through persistent changes in neural organization. Nevertheless, the principal subject remains signaling and behavioral regulation rather than a comprehensive explanation of autism, schizophrenia, or other neurodevelopmental diagnoses. Population associations with maternal infection do not imply that a particular person's condition was caused by such an exposure. The relevant scientific questions concern specific susceptible pathways, compensatory plasticity, dose and timing, and the degree to which experimentally defined animal mechanisms predict outcomes in independently followed human cohorts. Estes & McAllister (2016) Schafer et al. (2012) Wheeler & Quintana (2025)
Neuroimmune Signaling in Aging and Chronic Illness
Age and chronic illness alter the context in which neuroimmune signals operate. Immune-cell composition, tissue responsiveness, comorbid conditions, and neural resilience may change across the lifespan. Repeated inflammatory stimulation, chronic infection, metabolic disease, and neurodegenerative disorders can each modify peripheral and central immune states. The term chronic inflammation is too broad to identify a single causal pathway. Within behavioral neuroscience, it is essential to distinguish stable background elevation in a biomarker from recurrent symptomatic episodes, localized neural pathology, and sustained impairment of daily activity. Each pattern invites different measurement strategies and different causal hypotheses. Wheeler & Quintana (2025) Kovacs et al. (2025)
Brain-border immune surveillance provides a further research context. Meningeal and lymphatic structures communicate with the CNS and peripheral immune compartments, raising questions about immune drainage, aging, and disease. The discovery of meningeal lymphatic vessels supplies anatomical evidence that immune-related processes occur at interfaces historically underrepresented in brain models. It does not, by itself, show that altering drainage changes fatigue or reward processing in humans. A valid behavioral hypothesis would connect a defined border mechanism with a circuit-level mediator and a replicable task or symptom change while accounting for disease severity and the many processes associated with aging. Louveau et al. (2015) Smyth & Kipnis (2025)
Clinical cohorts are affected by treatment exposure, multimorbidity, survivor selection, and differences in health care access. Such factors can create apparent associations between inflammatory markers and psychological outcomes even when the biological pathway of interest has little direct behavioral effect. Longitudinal within-person designs help identify trajectories, although time-varying confounding and reverse causation remain concerns. The most compelling evidence for a proposed mechanism would combine temporally resolved immune measurements, central intermediate observations, and a selective intervention that changes the behavioral outcome. This standard is especially important when interpreting complex and persistent symptoms in older adults or people living with chronic diseases. Bower & Kuhlman (2023) Miller & Raison (2016) Wheeler & Quintana (2025)
Evolutionary and Ecological Accounts of Sickness
An evolutionary account asks why organisms might adjust behavior during immune challenge. Reduced foraging, increased resting, and reduced exposure to unfamiliar social contacts can plausibly conserve resources or change exposure to pathogens. Hart's influential synthesis proposed that sickness behavior forms an adaptive pattern, and later work connected that pattern to cytokine signaling. Functional plausibility should be distinguished from direct measurements of survival and reproductive consequences. Environmental conditions, social structure, predator exposure, and access to food or care can alter whether a given response is advantageous. The same phenotype may impose different costs in different ecological settings. Hart (1988) Dantzer et al. (2008)
Behavioral regulation under infection can be understood as a conditional decision system in which the value of actions depends on the body's changing state. A sick animal may accept a lower activity level when food is available, but engage strongly when offspring require protection or when immediate threat is high. This perspective predicts context-sensitive modulation rather than an invariant list of symptoms. It also motivates experiments measuring trade-offs among food, safety, contact, and effort instead of using one locomotor endpoint. Such trade-off designs could distinguish a motivational adjustment from generalized sensory or motor impairment when peripheral inflammation is experimentally induced. Konsman et al. (2002) Miller & Raison (2016) Wheeler & Quintana (2025)
For human societies, ecological context includes access to care, paid leave, housing, social support, and opportunities to reduce physical demands. An immune-linked reduction in behavior may be interpreted differently depending on those conditions. Evolutionary explanation is most useful when it generates measurable predictions about state-dependent prioritization, not when it retrospectively labels every illness symptom adaptive. Both useful short-term defense and harmful long-term impairment can emerge from the same signaling architecture under different conditions. This synthesis connects immune-to-brain signaling with behavioral ecology while preserving a distinction between testable functional hypotheses and established molecular pathways. Hart (1988) Dantzer et al. (2008) Slavich & Irwin (2014)
Experimental Paradigms and Causal Identification
Experimental neuroimmune research uses perturbations to establish temporal and causal relationships. In animals, lipopolysaccharide, isolated cytokines, receptor manipulations, vagotomy, cell-specific interventions, and controlled infection models help separate signaling routes. Each manipulation has consequences beyond the nominal target. A microbial component may induce many mediators, and surgery may alter baseline physiology independently of the pathway under study. Human endotoxin trials permit randomized assignment to an acute immune challenge and repeated behavioral testing under controlled conditions, creating stronger causal evidence for challenge effects than a cross-sectional correlation. Nevertheless, these trials identify the effect of the administered challenge, not the isolated effect of every induced cytokine. Dantzer et al. (1998) Maier et al. (1998) Eisenberger et al. (2010b)
Neural mediation requires more than demonstration that immune perturbation and neural change co-occur. An informative study specifies the pathway, manipulates it where feasible, measures a neural intermediate, and establishes whether the behavioral response changes when that mediator is selectively disrupted. Statistical mediation in a randomized challenge can support an explanatory model but depends on assumptions about mediator–outcome confounding. Brain imaging reveals functional signals rather than direct measurement of an inflammatory messenger. The strongest conclusions emerge from triangulation: experimental immune perturbation, route-specific neural tests, behavior-specific readouts, and replications across laboratories or independent samples. Eisenberger et al. (2010b) Felger et al. (2016) Wheeler & Quintana (2025)
A research design should match the temporal resolution of the hypothesized mechanism. Cytokines may change before subjective symptoms, while sleep, cognition, or mood can evolve later. Choosing a fixed testing point without a kinetic rationale can generate false negatives or misleading correlations. Baseline observations, randomized conditions, repeated immune measurements, physiologic controls, and prespecified primary behavioral endpoints strengthen inference. Where a procedure itself causes stress, experimenter contact, discomfort, and expectancy should be measured or balanced. The meaning of a statistically significant behavioral difference ultimately depends on its magnitude, reliability, duration, and specificity to the hypothesized neuroimmune pathway. Boyle et al. (2026) Bower & Kuhlman (2023) Dantzer et al. (2008)
Measurement Architecture: Biomarkers and Behavioral Constructs
Neuroimmune biomarkers span circulating cytokines, acute-phase proteins, immune-cell phenotypes, transcriptomic signals, and measures collected at brain interfaces. These indicators describe related but nonidentical processes. C-reactive protein reflects an acute-phase response and is not a direct measure of microglial activation; peripheral interleukin-6 need not correspond to the same concentration or signaling process within cerebrospinal fluid. Measurement quality depends on assay sensitivity, sample handling, detection limits, batch effects, diurnal timing, and recent illness. The scientific interpretation must state which compartment and process each biomarker is intended to index. Miller et al. (2002) Bower & Kuhlman (2023) Smyth & Kipnis (2025)
Behavioral measurements require equally explicit operational definitions. Reduced distance traveled can indicate lower locomotion, fatigue, altered exploration, or pain. A questionnaire item assessing lack of interest differs from a task measuring willingness to expend effort or neural response during reward anticipation. Social functioning involves observable contact, self-reported affiliation, and sensitivity to cues, which may diverge. A study that defines anhedonia solely through general mood ratings risks conflating distinct functions. Multimethod assessment can clarify whether immune challenge produces a broad syndrome or a selective change in the evaluation of incentives. Eisenberger et al. (2010b) Felger et al. (2016) Boyle et al. (2026)
Construct validity should be examined at the level of the causal question. When the hypothesis concerns immune effects on motivation, the design should compare reward preference, effort, psychomotor speed, and unpleasant physical symptoms. When it concerns social disconnection, tasks should distinguish perceived isolation from actual avoidance. Reliability and measurement invariance are essential for comparing age groups, health conditions, and cultures. Including several correlated biomarkers does not automatically provide convergent evidence if all respond to a common unmeasured confounder. Scientific progress depends on mapping each measurement to the mechanism and outcome it can legitimately support. Bower & Kuhlman (2023) Slavich & Irwin (2014) Boyle et al. (2026)
Human Studies, Population Variation, and Generalizability
Randomized human inflammatory challenges give particularly valuable evidence about acute causation, but their recruitment and safety constraints produce selective populations. A study involving healthy young adults can support a causal effect within the tested conditions while offering limited inference about older adults, children, patients with chronic disease, or people with complex medication histories. The 2026 Boyle study specifically enrolled female adults aged twenty-five through forty-four, demonstrating the importance of reporting sample composition and measurement schedule when generalizing. Individual immune responsivity, baseline mood, and behavioral context may all moderate effect size. Boyle et al. (2026) Eisenberger et al. (2010b)
Observational clinical studies complement challenge experiments by examining real-world illness, persistent symptoms, and broader exposures. They also introduce bidirectional causality: depression can influence sleep and activity, illness can alter mood, and both may change inflammatory biomarkers. Longitudinal designs improve temporal interpretation, especially with repeated measurements, but do not remove unmeasured confounding. Studies of stress and inflammation illustrate how caretaking burden, socioeconomic conditions, and physiology may co-vary. Reporting effect uncertainty, participant selection, coexisting conditions, and missing-data processes is therefore as important as naming a cytokine associated with a symptom. Miller et al. (2002) Felger et al. (2016) Slavich & Irwin (2014)
Between-species translation requires additional discipline. Rodent immune manipulations allow direct cellular intervention and well-controlled behavioral paradigms, while human studies can measure experiences such as social disconnection and subjective pleasure. The same label, such as depression-like behavior, may conceal different constructs in these settings. A mouse's reduced movement after lipopolysaccharide does not straightforwardly measure a human diagnostic syndrome. Convergent translation should connect homologous physiology and comparable behavioral computations rather than merely similar descriptions. Research conclusions should identify which claims arise from cellular experiments, human challenges, and clinical associations so that their evidential status remains visible. Dantzer et al. (2008) Estes & McAllister (2016) Miller & Raison (2016)
Replicability, Heterogeneity, and Scientific Disagreement
The neuroimmune literature contains robust demonstrations of immune-related changes in acute sickness, yet more variable findings about psychiatric symptoms and treatment effects. Differences in immune stimulus, dose, route, sampling interval, task, participant characteristics, and analytical decisions can explain part of this heterogeneity. Replication requires more than another study reporting significance for inflammation; it requires a sufficiently comparable exposure, measured mediator, and behavioral construct. Reporting null outcomes alongside positive findings helps distinguish specific pathways from selective publication of effects. The 2026 reward study is instructive because reduced social motivation coexisted with a more limited response of positive social cue processing. Boyle et al. (2026) Eisenberger et al. (2010b) Bower & Kuhlman (2023)
A major theoretical disagreement concerns whether elevated inflammation identifies a causal subgroup of depression, an associated consequence of illness and behavior, or several partially overlapping processes. Anti-inflammatory trial results have not established a general treatment benefit, and observational reward-circuit findings cannot determine causal direction. These results are compatible with conditional mechanisms and population heterogeneity. The hypothesis becomes stronger when a prespecified biomarker identifies patients who subsequently benefit from targeted modulation in independent trials. Until then, neither one intervention outcome nor a broad pooled biomarker association should be presented as a uniform clinical rule. Raison et al. (2013) Felger et al. (2016) Miller & Raison (2016)
Cell-state classifications and neural-connectome models introduce another area of debate. Advances in sequencing and imaging expose many immune-neural interactions but do not automatically show their functional importance for behavior. Descriptive cellular clusters can vary with tissue sampling, disease state, analysis pipeline, and species. The causal standard is selective perturbation combined with behavior, ideally within an experimentally justified anatomical circuit. Independent validation, preregistration of critical contrasts where feasible, complete reporting of exclusions, and open description of assays and statistical models can strengthen the field's credibility without reducing its complex biological object to an oversimplified biomarker signature. Wheeler & Quintana (2025) Kovacs et al. (2025) Smyth & Kipnis (2025)
Scientific Synthesis: A Multilevel Regulatory Model
The evidence supports a multilevel account in which immune detection, anatomical signaling, central integration, and behavioral allocation form an interactive system. Peripheral immune activation can signal through neural and humoral pathways; immune-associated cells at brain borders and within the CNS can influence local physiology; and autonomic and endocrine outputs can reshape immune function. Behavioral consequences emerge through neural systems governing effort, reward, feeding, social engagement, arousal, and defense. This synthesis is an organizing interpretation of the published literature, not a newly validated universal mathematical model. Its strength is that every proposed link can be associated with a class of experiments or measurements. Maier & Watkins (1998) Tracey (2002) Wheeler & Quintana (2025)
The model has four indispensable dimensions: location, signal identity, time, and behavioral specificity. Location distinguishes peripheral organs, vagal afferents, brain borders, and parenchymal cells. Signal identity distinguishes cytokines, neuronal activity, hormones, and cellular trafficking. Time separates initiation, acute adaptation, resolution, and long-term plasticity. Behavioral specificity distinguishes motivation, motor capacity, reward processing, threat, cognition, and subjective experience. Different experiments cover different slices of this system. The causal evidence for acute illness-related changes is stronger than broad claims about chronic psychological disorders, and developmental immune-neural functions must be analyzed on their own timescales. Schafer et al. (2012) Dantzer et al. (2008) Boyle et al. (2026)
This framework yields a practical hierarchy of claims. A measured biomarker change establishes a physiological association with the experimental condition. A randomized immune challenge with a changed behavior establishes a challenge effect on that behavior. Pathway-specific interference can establish contribution of a signaling route within the tested model. An independently replicated intervention improving an important clinical outcome can support a treatment claim. These are different achievements. The value of neuroimmune science lies in connecting them without skipping steps, thereby explaining both the coordinated organization of sickness behavior and the substantial heterogeneity of immune-linked symptoms in ordinary and clinical life. Eisenberger et al. (2010b) Raison et al. (2013) Wheeler & Quintana (2025)
Research Agenda: Mechanistic Resolution and Ecological Validity
Future research should identify which specific neuroimmune pathways change particular motivational computations. Combining time-resolved peripheral assays with anatomically informed brain measures, repeated symptom sampling, and effort-based choice tasks would sharpen the interpretation of inflammatory challenge studies. Experiments that test several reward domains can determine whether an immune manipulation affects anticipation, pursuit, pleasure, or social approach selectively. Cross-laboratory replication should focus on standardized timing and outcomes without suppressing informative variation. These approaches can convert broad associations into testable mechanistic statements with explicit effect magnitudes, confidence intervals, and relevant boundary conditions. Eisenberger et al. (2010b) Boyle et al. (2026) Bower & Kuhlman (2023)
A second priority is to connect cellular discoveries with human-relevant behavior. The growing study of meningeal and vascular immune interfaces makes it possible to test whether defined border processes alter specific neural computations. Developmental studies require follow-up designs that distinguish temporary inflammation from persistent circuit changes. Better human measurements of central immune processes could help, but any proposed marker must be independently validated against its intended biological target. The field should prioritize designs that combine region-specific mechanisms, organism-level physiology, and functional outcomes rather than accumulating molecular labels without a clear explanatory role. Louveau et al. (2015) Schafer et al. (2012) Smyth & Kipnis (2025)
An ecological agenda examines how immune state affects behavior outside laboratory testing. Daily mobility, work demands, social opportunity, sleep, and access to care may influence whether a transient sickness response causes serious functional disruption. Repeated digital assessments and wearable physiological measurements might capture change over time, provided their limitations are modeled explicitly. In the Artificial Era, human–artificial tools may support behavioral logging or adaptive assistance, but this is a methodological prospect, not evidence that artificial systems possess immune physiology or human sickness experience. Any computational inference should be validated against independently measured health and behavior and governed by privacy-preserving protocols. Hart (1988) Bower & Kuhlman (2023) Wheeler & Quintana (2025)
Conclusion
Neuroimmune signaling is a central mechanism of behavioral regulation because immune detection and neural control participate in a reciprocal system that changes activity, motivation, social engagement, feeding, sleep, affect, and cognitive performance. Historical research established the concept of illness-related behavioral organization, identified cytokine-sensitive pathways, and demonstrated neural regulation of immune responses. Controlled animal perturbations established cellular and anatomical mechanisms, while randomized human inflammatory challenges showed that temporary immune activation can alter reward-related neural responses, mood, and social motivation. Recent anatomy and systems biology further establish the importance of brain borders, meningeal pathways, and heterogeneous cellular interactions. Hart (1988) Eisenberger et al. (2010b) Wheeler & Quintana (2025)
The combined evidence also defines the limits of current explanation. A circulating inflammatory marker cannot on its own demonstrate brain inflammation or identify a specific behavioral mechanism. Associations between inflammatory biomarkers and depression leave causal direction unresolved; randomized anti-inflammatory treatment studies have not demonstrated uniform efficacy across heterogeneous clinical populations. Animal microglial and maternal immune activation findings reveal biologically important mechanisms but require additional tests before being assigned precise clinical meanings for humans. These limits are research instructions: state the compartment, pathway, timing, task, and inference level before making a claim about behavior. Raison et al. (2013) Schafer et al. (2012) Estes & McAllister (2016)
The fundamental scientific synthesis is a conditional account of reciprocal regulation. Immune signals convey bodily information to neural systems; neural outputs influence immune organization; and the behavioral result depends on the pathway engaged, physiological history, environmental demands, and available alternatives for action. Progress will come from experiments that connect molecular and neural events to well-defined behavioral functions, from independent replication, and from clinical trials that test prespecified mechanisms and meaningful outcomes. This monograph treats neuroimmune signaling as an identifiable field of causal investigation whose explanatory scope is established by convergent evidence rather than by a single molecule or diagnostic label. Dantzer et al. (2008) Bower & Kuhlman (2023) Wheeler & Quintana (2025)
References
- Blalock, J. E. (1984). The immune system as a sensory organ. Journal of Immunology, 132(3), 1067–1070. https://doi.org/10.4049/jimmunol.132.3.1067
- Bower, J. E., & Kuhlman, K. R. (2023). Psychoneuroimmunology: An introduction to immune-to-brain communication and its implications for clinical psychology. Annual Review of Clinical Psychology, 19, 331–359. https://doi.org/10.1146/annurev-clinpsy-080621-045153
- Boyle, C. C., Blandl, F., Eisenberger, N. I., Olmstead, R., Cho, J. H., Piber, D., & Irwin, M. R. (2026). Effects of acute inflammatory challenge on anhedonia and social reward processing: A randomized controlled trial of endotoxin. Psychoneuroendocrinology, 193, Article 107987. https://doi.org/10.1016/j.psyneuen.2026.107987
- Capuron, L., Ravaud, A., & Dantzer, R. (2000). Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. Journal of Clinical Oncology, 18(10), 2143–2151. https://doi.org/10.1200/JCO.2000.18.10.2143
- Dantzer, R., Bluthé, R.-M., Layé, S., Bret-Dibat, J.-L., Parnet, P., & Kelley, K. W. (1998). Cytokines and sickness behavior. Annals of the New York Academy of Sciences, 840, 586–590. https://doi.org/10.1111/j.1749-6632.1998.tb09597.x
- Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience, 9, 46–56. https://doi.org/10.1038/nrn2297
- Derecki, N. C., Cardani, A. N., Yang, C. H., Quinnies, K. M., Crihfield, A., Lynch, K. R., & Kipnis, J. (2010). Regulation of learning and memory by meningeal immunity: A key role for IL-4. Journal of Experimental Medicine, 207(5), 1067–1080. https://doi.org/10.1084/jem.20091419
- Eisenberger, N. I., Inagaki, T. K., Mashal, N. M., & Irwin, M. R. (2010). Inflammation and social experience: An inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain, Behavior, and Immunity, 24(4), 558–563. https://doi.org/10.1016/j.bbi.2009.12.009
- Eisenberger, N. I., Berkman, E. T., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2010). Inflammation-induced anhedonia: Endotoxin reduces ventral striatum responses to reward. Biological Psychiatry, 68(8), 748–754. https://doi.org/10.1016/j.biopsych.2010.06.010
- Estes, M. L., & McAllister, A. K. (2016). Maternal immune activation: Implications for neuropsychiatric disorders. Science, 353(6301), 772–777. https://doi.org/10.1126/science.aag3194
- Felger, J. C., Li, Z., Haroon, E., Woolwine, B. J., Jung, M. Y., Hu, X., & Miller, A. H. (2016). Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Molecular Psychiatry, 21, 1358–1365. https://doi.org/10.1038/mp.2015.168
- Hart, B. L. (1988). Biological basis of the behavior of sick animals. Neuroscience & Biobehavioral Reviews, 12(2), 123–137. https://doi.org/10.1016/S0149-7634(88)80004-6
- Konsman, J. P., Parnet, P., & Dantzer, R. (2002). Cytokine-induced sickness behaviour: Mechanisms and implications. Trends in Neurosciences, 25(3), 154–159. https://doi.org/10.1016/S0166-2236(00)02088-9
- Kovacs, M., Dominguez-Belloso, A., Ali-Moussa, S., & Deczkowska, A. (2025). Immune control of brain physiology. Nature Reviews Immunology, 25, 515–527. https://doi.org/10.1038/s41577-025-01129-6
- Leunig, A., Gianeselli, M., Russo, S. J., & Swirski, F. K. (2025). Connection and communication between the nervous and immune systems. Nature Reviews Immunology, 25, 912–933. https://doi.org/10.1038/s41577-025-01199-6
- Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., Harris, T. H., & Kipnis, J. (2015). Structural and functional features of central nervous system lymphatic vessels. Nature, 523, 337–341. https://doi.org/10.1038/nature14432
- Maier, S. F., Goehler, L. E., Fleshner, M., & Watkins, L. R. (1998). The role of the vagus nerve in cytokine-to-brain communication. Annals of the New York Academy of Sciences, 840, 289–300. https://doi.org/10.1111/j.1749-6632.1998.tb09569.x
- Maier, S. F., & Watkins, L. R. (1998). Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Review, 105(1), 83–107. https://doi.org/10.1037/0033-295X.105.1.83
- Miller, A. H., & Raison, C. L. (2016). The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology, 16, 22–34. https://doi.org/10.1038/nri.2015.5
- Miller, G. E., Cohen, S., & Ritchey, A. K. (2002). Chronic psychological stress and the regulation of pro-inflammatory cytokines: A glucocorticoid-resistance model. Health Psychology, 21(6), 531–541. https://doi.org/10.1037/0278-6133.21.6.531
- Raison, C. L., Rutherford, R. E., Woolwine, B. J., Chen, S., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013). A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry, 70(1), 31–41. https://doi.org/10.1001/2013.jamapsychiatry.4
- Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012). Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron, 74(4), 691–705. https://doi.org/10.1016/j.neuron.2012.03.026
- Slavich, G. M., & Irwin, M. R. (2014). From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychological Bulletin, 140(3), 774–815. https://doi.org/10.1037/a0035302
- Smyth, L. C. D., & Kipnis, J. (2025). Redefining CNS immune privilege. Nature Reviews Immunology, 25, 766–775. https://doi.org/10.1038/s41577-025-01175-0
- Tracey, K. J. (2002). The inflammatory reflex. Nature, 420, 853–859. https://doi.org/10.1038/nature01321
- Watkins, L. R., & Maier, S. F. (1999). Implications of immune-to-brain communication for sickness and pain. Proceedings of the National Academy of Sciences of the United States of America, 96(14), 7710–7713. https://doi.org/10.1073/pnas.96.14.7710
- Wheeler, M. A., & Quintana, F. J. (2025). The neuroimmune connectome in health and disease. Nature, 638, 333–342. https://doi.org/10.1038/s41586-024-08474-x
Social Withdrawal, Affiliation, and Interpersonal Context
Inflammation can change how social opportunities are represented, approached, or avoided. Some responses resemble withdrawal from stimulation during illness; others depend on the kind of social interaction available, perceived support, and risk of exposure. In a human inflammatory-challenge study, Eisenberger and colleagues found increased feelings of social disconnection alongside depressed mood. The finding gives experimental support to an effect of an inflammatory challenge on social experience. It does not mean that all social behavior declines or that the same processes explain affiliation, sensitivity to rejection, social pleasure, and interpersonal trust. Distinct tasks are necessary to identify which dimensions change. Eisenberger et al. (2010a) Bower & Kuhlman (2023)
Social behavior is particularly sensitive to contextual interpretation. Withdrawal from strangers during contagious illness may have different consequences than seeking care from familiar people. A robust explanatory model therefore includes interaction partner, setting, task instruction, perceived safety, and the timing of infection-related symptoms. Measurements should separate desire for affiliation from fear of evaluation, subjective loneliness from observed contact, and emotion recognition from the incentive to engage. When social motivation changes after experimentally induced inflammation, the resulting behavioral effect may arise from altered valuation, fatigue, bodily discomfort, or threat processing acting alone or together. Eisenberger et al. (2010a) Boyle et al. (2026) Slavich & Irwin (2014)
The reciprocal direction also matters: adverse social conditions may precede inflammatory change. Slavich and Irwin's social signal transduction theory proposes that perceived social threat engages neural and physiological responses capable of altering inflammatory activity, with downstream effects on mood and behavior. The account integrates psychosocial appraisal and immune processes, but individual causal arrows require empirical discrimination. Stressful experiences are associated with sleep loss, changed activity, and other factors that influence biomarkers. Longitudinal measurements and randomized psychological interventions can help evaluate whether social stress contributes to inflammatory trajectories independently of these co-occurring pathways. Slavich & Irwin (2014) Miller et al. (2002) Bower & Kuhlman (2023)